Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Agenus Inc (AGEN)

Agenus Inc (AGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 39,294
  • Shares Outstanding, K 23,459
  • Annual Sales, $ 156,310 K
  • Annual Income, $ -245,760 K
  • EBIT $ -99 M
  • EBITDA $ -85 M
  • 60-Month Beta 1.23
  • Price/Sales 0.42
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 203.94% ( -14.38%)
  • Historical Volatility 91.67%
  • IV Percentile 85%
  • IV Rank 34.39%
  • IV High 452.62% on 11/12/24
  • IV Low 73.60% on 03/20/24
  • Put/Call Vol Ratio 0.03
  • Today's Volume 31
  • Volume Avg (30-Day) 284
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 12,088
  • Open Int (30-Day) 12,447

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -1.86
  • Number of Estimates 3
  • High Estimate -1.17
  • Low Estimate -2.29
  • Prior Year -3.04
  • Growth Rate Est. (year over year) +38.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6508 +12.67%
on 03/14/25
3.6000 -48.33%
on 02/18/25
-1.6500 (-47.01%)
since 02/14/25
3-Month
1.6508 +12.67%
on 03/14/25
4.1500 -55.18%
on 01/22/25
-1.1900 (-39.02%)
since 12/13/24
52-Week
1.6508 +12.67%
on 03/14/25
19.6880 -90.55%
on 06/04/24
-10.1340 (-84.49%)
since 03/14/24

Most Recent Stories

More News
Agenus (AGEN) Q4 2024 Earnings Call Transcript

AGEN earnings call for the period ending December 31, 2024.

AGEN : 1.8600 (+11.04%)
Agenus: Q4 Earnings Snapshot

Agenus: Q4 Earnings Snapshot

AGEN : 1.8600 (+11.04%)
Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium

/CNW/ -- USA News Group News Commentary – Big developments are expected this week at the 2025 ASCO Gastrointestinal Cancers Symposium, running January 23-25 in...

ONCY : 0.6250 (+0.32%)
AGEN : 1.8600 (+11.04%)
GH : 42.89 (+5.54%)
XLO : 0.8002 (+0.15%)
ONC.TO : 0.91 (unch)
RNXT : 0.9858 (-3.35%)
Agenus (AGEN) Q3 2024 Earnings Call Transcript

AGEN earnings call for the period ending September 30, 2024.

AGEN : 1.8600 (+11.04%)
Agenus: Q3 Earnings Snapshot

Agenus: Q3 Earnings Snapshot

AGEN : 1.8600 (+11.04%)
Agenus (AGEN) Q2 2024 Earnings Call Transcript

AGEN earnings call for the period ending June 30, 2024.

AGEN : 1.8600 (+11.04%)
Agenus: Q2 Earnings Snapshot

Agenus: Q2 Earnings Snapshot

AGEN : 1.8600 (+11.04%)
3 Magnificent Growth Stocks to Buy Hand Over Fist

Small-cap stocks could get a boost from the central bank's anticipated rate cuts in 2025. These three stocks may be a great way to get ahead of this catalyst.

LGND : 106.19 (+0.54%)
AGEN : 1.8600 (+11.04%)
CGC : 1.1000 (+4.76%)
CURLF : 0.9370 (+1.84%)
Agenus (AGEN) Q1 2024 Earnings Call Transcript

AGEN earnings call for the period ending March 31, 2024.

AGEN : 1.8600 (+11.04%)
Agenus: Q1 Earnings Snapshot

Agenus: Q1 Earnings Snapshot

AGEN : 1.8600 (+11.04%)

Business Summary

Agenus Inc., formerly known as Antigenics Inc., is engaged in the discovery, development and commercialization of immunotherapeutics for the treatment of life threatening and chronic medical conditions. Immunotherapeutics are drugs that work by modulating the immune system to fight diseases. The Company's...

See More

Key Turning Points

3rd Resistance Point 2.2223
2nd Resistance Point 2.0661
1st Resistance Point 1.9631
Last Price 1.8600
1st Support Level 1.7039
2nd Support Level 1.5477
3rd Support Level 1.4447

See More

52-Week High 19.6880
Fibonacci 61.8% 12.7978
Fibonacci 50% 10.6694
Fibonacci 38.2% 8.5410
Last Price 1.8600
52-Week Low 1.6508

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar